Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Mdaw94on Dec 21, 2017 4:01pm
147 Views
Post# 27209289

RE:RE:RE:RE:RE:I really don't get it

RE:RE:RE:RE:RE:I really don't get it275 million for Newstrike is approx 10 times to much to pay. Clearly a panic move posion pill tactic. No doubt to make Cmed look less attractive. Cmed is a great company with an amazing product line that will look great in all the pharmacys in Canada and Europe. However the deal is more then fair. Higher premium then Canopy paid for Mettrum. Zettl is running scared. If he wanted a better deal he should have just picked up the phone in the first place. To even mention anything involving the US right now is just negligence. Do you really think the house republicans are going to find it in there hearts to re insert Obamas protection amendment ( protected state run MJ programs from federal interference)into the spending bill coming up? Once that amendment expires ( which is shortly) Session will be licking his chompers. 
Let Cmed shareholders vote today, that's all Acb is asking. Get ready done, lots more to do!
Bullboard Posts